Skip to Main Content

Author Details

Fang Feng
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
2010
40
10
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36865494Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial.Open Med (Wars)2023
37598189Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.Mol Cancer2023
38045044Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma.Acta Pharm Sin B2023
36971698Application of a flexible visitation system in critically ill patients: A randomized clinical trial.Sci Prog2023
37134203Design, Synthesis, and Evaluation of (<i>R</i>)-8-((Tetrahydrofuran-2-yl)methyl)pyrido[2,3-<i>d</i>]pyrimidin-7-ones as Novel Selective ACK1 Inhibitors to Combat Acquired Resistance to the Third-Generation EGFR Inhibitor.J Med Chem2023
36605493Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation <i>in vitro</i> and <i>in vivo</i>.J Cancer2023
35587686Identification of 1<i>H</i>-pyrazolo[3,4-b]pyridine derivatives as novel and potent TBK1 inhibitors: design, synthesis, biological evaluation, and molecular docking study.J Enzyme Inhib Med Chem2022
33480633Reply to "Can the simple parameter of peripheral hematological examination predict the outcome in patients with septic acute kidney injury?"J Chin Med Assoc2021
33787414Effect of vitamin C in critically ill patients with sepsis and septic shock: A meta-analysis.Sci Prog2021
33834967[Safety of administration of norepinephrine through peripheral vein line in patients with septic shock].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2021
34586366Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.JAMA Netw Open2021
34698240Mind-Body Therapies for Cancer Patients Living with Depression, Anxiety or Insomnia (MIRACLE): A Systematic Review with Individual Participant Data Network Meta-Analysis.Methods Protoc2021
34404402Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.Mol Cancer2021
34003691The epidemiology of acute kidney injury in critically ill patients in the Gansu Province: The EACG study.Sci Prog2021
32404161Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.Mol Cancer2020
32062945[Awareness, treatment and control of hypertension in 640 000 adults in eastern China].Zhonghua Liu Xing Bing Xue Za Zhi2020
33289843Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China.JAMA Netw Open2020
32773589Relationship between platelet/lymphocyte ratio and prognosis of patients with septic acute kidney injury: A pilot study.J Chin Med Assoc2020
32788015[Application of a risk stratification-based model for prediction of acute kidney injury combined with hemoperfusion in patients with sepsis: a prospective, observational, pilot study].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2020
31140992Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis.Chin Med J (Engl)2019
31415421Development of a risk stratification-based model for prediction of acute kidney injury in critically ill patients.Medicine (Baltimore)2019
31223440Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR<sup>L858R/T790M/C797S</sup>.ACS Med Chem Lett2019
293557517α,8α-Epoxynagilactones and their glucosides from the twigs of Podocarpus nagi: Isolation, structures, and cytotoxic activities.Fitoterapia2018
29968849Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R.Acta Pharmacol Sin2018
29906114Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.J Med Chem2018
30293333[The efficacy of cognitive behavioral therapy in insomnic patients with or without comorbidities: a pilot study].Zhonghua Nei Ke Za Zhi2018
30546393PVT1 regulates inflammation and cardiac function via the MAPK/NF-κB pathway in a sepsis model.Exp Ther Med2018
30387654GW170817: Measurements of Neutron Star Radii and Equation of State.Phys Rev Lett2018
28589724C-H Trifluoromethylation of 2-Substituted/Unsubstituted Aminonaphthoquinones at Room Temperature with Bench-Stable (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>Zn: Synthesis and Antiproliferative Evaluation.J Org Chem2017
26945565The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design.Catheter Cardiovasc Interv2016
26805535[Study of prevention and control of delirium in ventilated patients by simulating blockage of circadian rhythm with sedative in intensive care unit].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2016
26712436China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study Design.Chin Med J (Engl)2016
25124901[Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014
23651962[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study].Zhonghua Xin Xue Guan Bing Za Zhi2013
24034088National survey of doctor-reported secondary preventive treatment for patients with acute coronary syndrome in China.Chin Med J (Engl)2013
22748463[Clinical evaluation of compound rhubarb preparation treating acute respiratory distress syndrome patients in plateau areas].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue2012
23253702Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.Chin Med J (Engl)2012
22800887Underuse of statins in patients with atherosclerotic ischemic stroke in China.Chin Med J (Engl)2012
21781591[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].Zhonghua Xin Xue Guan Bing Za Zhi2011
21162998[A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China].Zhonghua Liu Xing Bing Xue Za Zhi2010
  • 1 - 40 of 40

Recommended Authors

The First Medical Center, The General Hospital of PLA
Career Start Year 2016
Number of shared co-authors 0
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Affiliated Jinhua Hospital, Zhejiang University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
University Hospital RWTH Aachen
Career Start Year 2013
Number of shared co-authors 0
Chinese PLA General Hospital
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 2012
Number of shared co-authors 0
The First Medical Center, Chinese PLA General Hospital
Career Start Year 2010
Number of shared co-authors 1
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Harvard Medical School, Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 0
University of Florence
Career Start Year 2009
Number of shared co-authors 0
Ambroise Pare Hospital
Career Start Year 2008
Number of shared co-authors 0
Chulalongkorn University
Career Start Year 2006
Number of shared co-authors 0
Zhongnan Hospital of Wuhan University
Career Start Year 2006
Number of shared co-authors 0
Mayo Clinic Rochester
Career Start Year 2006
Number of shared co-authors 0
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Chinese People's Liberation Army (PLA) General Hospital
Career Start Year 2005
Number of shared co-authors 0
Osaka City University Graduate School of Medicine
Career Start Year 2003
Number of shared co-authors 0
The First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2003
Number of shared co-authors 0
Hospital Israelita Albert Einstein
Career Start Year 2003
Number of shared co-authors 0
Apollo Hospitals
Career Start Year 2000
Number of shared co-authors 0
Goethe University, University Hospital Frankfurt
Career Start Year 1997
Number of shared co-authors 0
King Abdullah International Medical Research Center
Career Start Year 1997
Number of shared co-authors 0
Fujian Medical University Union Hospital
Career Start Year 1996
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Radboud University Medical Centre
Career Start Year 1995
Number of shared co-authors 0
University of Helsinki and Helsinki University Hospital
Career Start Year 1991
Number of shared co-authors 0
Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)
Career Start Year 1991
Number of shared co-authors 0
The University of Tokyo Hospital
Career Start Year 1989
Number of shared co-authors 0
Centre Hospitalier Regional Mons-Hainaut
Career Start Year 1986
Number of shared co-authors 0

Collaborators

Fuwai Hospital Chinese Academy of Medical Sciences Shenzhen China.
Co-authored papers 10
First Affiliated Hospital of Guangxi Medical University
Co-authored papers 9
Renji Hospital, Shanghai Jiao Tong University
Co-authored papers 8
Co-authored papers 6
Shiyan Emergency Medical Center
Co-authored papers 6
Yale School of Medicine
Co-authored papers 4
Keenan Research Centre for Biomedical Science of St. Michael's Hospital
Co-authored papers 3
Fuwai Hospital, Chinese Academy of Medical Sciences
Co-authored papers 2
Center for Outcomes Research and Evaluation, Yale New Haven Hospital
Co-authored papers 2
Center for Outcomes Research and Evaluation, Yale University School of Medicine
Co-authored papers 2
University of Missouri-Kansas City School of Medicine
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Co-authored papers 2
Co-authored papers 2
Center for Outcomes Research and Evaluation, Yale University School of Medicine
Co-authored papers 2
Dalian University of Technology
Co-authored papers 1
College of Health and Human Sciences, Purdue University
Co-authored papers 1
The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University
Co-authored papers 1
Albert-Einstein-Institut, Max-Planck-Institut fur Gravitationsphysik
Co-authored papers 1
Center for Outcomes Research and Evaluation, Yale New Haven Hospital (L.M.
Co-authored papers 1
Fuwai Hospital Chinese Academy of Medical Sciences
Co-authored papers 1
University of Adelaide
Co-authored papers 1
Yale University
Co-authored papers 1
Co-authored papers 1
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
City University of Hong Kong
Co-authored papers 1
Co-authored papers 1
Yale University
Co-authored papers 1